We are looking for an edge. We do not claim to have one.
Over 1,400 hypotheses tested on NQ and ES in five months, with a sealed holdout, DSR deflated on the global N, and cross-validation. To date, none has cleared our bar. The latest forward test is negative. We sell no signal until an edge is confirmed in forward — and we will write it here when it is.
Why you see no numbers here : because no strategy has been validated. Out of 1,400 hypotheses, only one came out positive — fewer than chance alone produces at that number of trials. Showing a flattering curve would be easy; it would be a lie.
The bar before the trial
The threshold is set and sealed before testing: a holdout never reopened, DSR deflated on the total number of trials, cross-validation. We never move the bar to let a strategy through.
Real costs included
Commissions and slippage are simulated and stress-raised. An edge that breaks under realistic fees is not an edge.
Chance counts double
At 1,400 trials, chance alone produces dozens of false positives. That is why a single positive hypothesis proves nothing, and why we do not sell it.
This page describes a research process, not a result. Past performance, when there is any, will never predict future performance. Trading carries a risk of total capital loss. Educational and analytical content, not investment advice.
The desk, meanwhile, runs every day.
The research is still searching. The order flow method, on the other hand, is learned and practised — the crew shows it in the open, every day.
Trading involves a risk of loss. No gain is guaranteed. Past performance does not predict future results.
Weekly brief
A concise market read, without noise.
Each week: market regime, CME levels, method notes and risk reminders. No promise, no spam, one-click unsubscribe.
Your data is processed in accordance with our privacy policy.